These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6207731)

  • 21. A double-blind clinical trial wtih cromoglycate eye drops in patients with atopic conjunctivitis.
    Simon-Licht IF; Dieges PH
    Ann Allergy; 1982 Oct; 49(4):220-4. PubMed ID: 6812469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case for conservative management of adenoviral pseudomembranous conjunctivitis.
    Gilmour KM; Ramaesh K
    BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36810328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Letter: Epidemic conjunctivitis due to B type adenovirus].
    Obert G; Gut JP; Lab M; Kirn A
    Nouv Presse Med; 1975 Nov; 4(38):2731. PubMed ID: 172869
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
    Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
    Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and etiological study of adenovirus conjunctivitis, 1979-1980, Sapporo, Japan: with special reference to the infection with types 4 and 19 (author's transl)].
    Aoki K; Kato M; Ohtsuka H; Nakazono N; Ishii K
    Nippon Ganka Gakkai Zasshi; 1981 Aug; 85(8):1066-74. PubMed ID: 6274173
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxymetazoline ophthalmic solution versus naphazoline solution in non-infectious conjunctivitis.
    Rybiczka R; Mauracher E
    Pharmatherapeutica; 1983; 3(6):376-81. PubMed ID: 6353428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, multi-centre controlled trial of 0.25% oxymetazoline ophthalmic solution in patients with allergic and non-infectious conjunctivitis.
    Breakey AS; Cinotti AA; Hirshman M; Skowron RA; Samson CR; Danzig MR
    Pharmatherapeutica; 1980; 2(6):353-6. PubMed ID: 7433476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of ragweed allergic conjunctivitis with 2% cromolyn solution in unit doses.
    Nizami RM
    Ann Allergy; 1981 Jul; 47(1):5-7. PubMed ID: 6789720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human fibroblast interferon in tears of patients with picornavirus epidemic conjunctivitis.
    Langford MP; Yin-Murphy M; Ho YM; Barber JC; Baron S; Stanton GJ
    Infect Immun; 1980 Sep; 29(3):995-8. PubMed ID: 6159329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nosocomial conjunctivitis caused by adenovirus type 4.
    Levandowski RA; Rubenis M
    J Infect Dis; 1981 Jan; 143(1):28-31. PubMed ID: 6260867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
    Abelson MB; Berdy GJ; Mundorf T; Amdahl LD; Graves AL;
    J Ocul Pharmacol Ther; 2002 Oct; 18(5):475-88. PubMed ID: 12419098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonococcal conjunctivitis.
    Harbin T; Curran RE
    Ann Ophthalmol; 1974 Mar; 6(3):221-4. PubMed ID: 4205793
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute haemorrhagic conjunctivitis caused by a subtype of adenovirus type 37].
    Higuchi M; Nakazono N; Ishii K; Ohno S; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1985 May; 89(5):692-5. PubMed ID: 2992248
    [No Abstract]   [Full Text] [Related]  

  • 34. Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis.
    Kemp JP; Buckley CE; Gershwin ME; Buchman E; Cascio FL; Chretien JH; Foster TS; Gordon WE; Jakle C; Klemawesch SJ
    Ann Allergy; 1985 Jun; 54(6):502-9. PubMed ID: 2861767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-associated acute conjunctivitis in Beijing, China, 2011-2013.
    Li J; Lu X; Jiang B; Du Y; Yang Y; Qian H; Liu B; Lin C; Jia L; Chen L; Wang Q
    BMC Infect Dis; 2018 Mar; 18(1):135. PubMed ID: 29558885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus type 11 epidemic conjunctivitis in Singapore.
    Yin-Murphy M; Lim KH; Chua PH
    Southeast Asian J Trop Med Public Health; 1974 Sep; 5(3):333-41. PubMed ID: 4372722
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxatomide effects in follicular conjunctivitis of presumed allergic cause. A double-blind evaluation.
    Blockeel J; Leuridan O
    Ophthalmologica; 1980; 181(3-4):133-8. PubMed ID: 7015215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tobramycin in external eye disease: a double-masked study vs. gentamicin.
    Leibowitz HM; Hyndiuk RA; Smolin GR; Nozik RA; Hunter GJ; Cagle GD; Davis DS
    Curr Eye Res; 1981; 1(5):259-66. PubMed ID: 7030632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.